Non-Hodgkin lymphoma overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{Non-Hodgkin lymphoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Hematology}} {{Hematological malignancy histology}} {{SIB}} [[bn:অ-হজকিনের ল...")
 
Line 3: Line 3:


==Overview==
==Overview==
'''Non-Hodgkin lymphoma''' (NHL) describes a group of [[cancer]]s arising from [[lymphocyte]]s, a type of [[white blood cell]]. It is distinct from [[Hodgkin lymphoma]] in its [[pathology|pathologic features]], [[epidemiology]], common sites of involvement, clinical behavior, and treatment. The non-Hodgkin lymphomas are a diverse group of diseases with varying courses, treatments, and[[prognosis|prognoses]].
[[Image:|frame|left|Malignant lymphoma, high grade B cell, not otherwise specified Courtesy of  Ed Uthman, MD]]
Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system (e.g. [[spleen]], [[lymph node]]s, or [[tonsils]]). Most cases start with infiltration of lymph nodes, but some subtypes may be restricted to other lymphatic organs.
The diagnosis of non-Hodgkin lymphoma requires a [[biopsy]] of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness, or histologic grade. These categories are ''indolent''(or low-grade), ''aggressive'' (or intermediate-grade), and ''highly aggressive'' (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with [[chemotherapy]] and/or [[radiation therapy]].


==References==
==References==

Revision as of 21:20, 20 January 2012

Non-Hodgkin lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Hodgkin's Lymphoma

Differentiating Non-Hodgkin Lymphoma from Other Diseases
Differentiating Types of Non-Hodgkin's Lymphoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Hodgkin lymphoma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Hodgkin lymphoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Hodgkin lymphoma overview

CDC on Non-Hodgkin lymphoma overview

Non-Hodgkin lymphoma overview in the news

Blogs on Non-Hodgkin lymphoma overview

Directions to Hospitals Treating Non-Hodgkin lymphoma

Risk calculators and risk factors for Non-Hodgkin lymphoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Non-Hodgkin lymphoma (NHL) describes a group of cancers arising from lymphocytes, a type of white blood cell. It is distinct from Hodgkin lymphoma in its pathologic features, epidemiology, common sites of involvement, clinical behavior, and treatment. The non-Hodgkin lymphomas are a diverse group of diseases with varying courses, treatments, andprognoses.

[[Image:|frame|left|Malignant lymphoma, high grade B cell, not otherwise specified Courtesy of Ed Uthman, MD]]

Non-Hodgkin lymphoma may develop in any organ associated with the lymphatic system (e.g. spleen, lymph nodes, or tonsils). Most cases start with infiltration of lymph nodes, but some subtypes may be restricted to other lymphatic organs.

The diagnosis of non-Hodgkin lymphoma requires a biopsy of involved tissue. The numerous subtypes of non-Hodgkin lymphoma are typically grouped into three distinct categories based on their aggressiveness, or histologic grade. These categories are indolent(or low-grade), aggressive (or intermediate-grade), and highly aggressive (or high-grade). The treatment of indolent or low-grade lymphoma may initially involve a period of observation, while aggressive or highly aggressive non-Hodgkin lymphoma is typically treated with chemotherapy and/or radiation therapy.

References

Template:Hematology

Template:SIB bn:অ-হজকিনের লসিকার্বুদ de:Non-Hodgkin-Lymphom nl:Non-Hodgkin fi:Non-Hodgkinin lymfooma sv: Non-Hodgkins lymfom


Template:WikiDoc Sources